Blue Horseshoe Stocks: AYTU Update & More

Aytu BioScience, Inc. AYTU Yesterday morning, we were just discussing AYTU and the modest progress the stock had made since we flagged it as a bottom play in Wednesday’s premarket report. Not only had it displayed a cherry bottom setup, but we noted a string of insider buysat the time as well.Following that report, we would witness a low of .4118, and over the course of the ensuing four trading days, the stock has made a noteworthy move and continues to exhibit signs that more gains could be in store.

Yesterday it reached .61, which represents a run of 48% in under a week. It did so on record volume, so we’re definitely eager to see where the momentum could carry this play that was already on its way back up.


InspireMD, Inc. NSPR

NSPR has been in real trouble in 2018, losing ground at seemingly every turn and unable to get out of its own way. However, through a combination of a South American breakthrough announcement for two of the companies drugs, and being just plain oversold, we’re seeing a marginal premarket gap-up and will want to observe for a more sustained rebound.

The news was pertaining to NSPR receiving regulatory approval from the goverment of Peru for its CGuard™ Embolic Prevention System (EPS) and MGuard Prime™ products. Peru has a population of more than 30 million people. (>>View PR)


Extended Watchlist:
ARWR, GLOW, MDGS, MBRX, SEE, WBAI, LIQT, PIXY,

Incoming search terms:

  • T2AV

Blue Horseshoe Stocks: SVSN Review & More

Stereo Vision Entertainment, Inc. SVSN

It was roughly six weeks back that we put SVSN on our radars on a routine news scan, and as we always say, it’s better to be early to the party than late. All the way up until last week, the stock wasn’t trading with any real vigor, but things have picked in a huge way, both in volume and price.

From its low at .08 at the beginning of last week, the stock finished out at a high of .89, for an intraweek rip of 1012% This came on the news that the company will file a $50M Real Estate Investment Trust on behalf of its CannaVision subsidiary, with the goal of organically growing cannabis for the purposes of extracting CBD.


Progressive Care, Inc. RXMD

We also want to swing back around to RXMD this morning, which we intially tagged onthe morning of February 22nd. Since that time the stock has exhibited a fairly steady climb up the chart.

We observed a low of .0663 in RXMD on that first day, and as of Friday’s new high of .129, we had watched as the stock rose 95% over a period of just seven trading sessions. It’s streaking to its highest PPS in nearly five years, so it’s safe to say RXMD is in blue sky breakout territory, and we’ll be eager to continue tracking its movements.



Fate Therapeutics, Inc. FATE

We also wanted to recap the solid move we’ve witnessed in FATE, since mentioning the stock toward the end of January. It dipped slightly to a low of 6.76 shortly thereafter, and has since gone a very impressive run.

The stock reached a new high of 14.02 on Friday, which worked out to a 108% upswing in a matter of less than a month.


Extended Watchlist:
RJDG, ATNM, INPX, NSPR, GNL, OTIV, CLSD, MYSZ

Incoming search terms:

  • svsn stock scam

Blue Horseshoe Stocks: SPY Ripping & More

SPDR S&P 500 ETF (SPY)

Fresh for yesterday’s premarket report was an idea we formulated for the SPY after it appeared we were headed for another bullish session, the SPY Weekly $270-272 Calls. When the markets behaved as we suspected they would, that provided us with some really great chances for single-session profits in our target contracts.

The gains were strong across the board, with the following excellent moves being made on the day:

$270 Calls – Range: .85-3.44 – Max Gain: 304%
$270.50 Calls – Range: .70-2.98 – Max Gain: 326%
$271 Calls – Range: .52-2.59 – Max Gain: 398%
$271.50 Calls – Range: .39-2.14 – Max Gain: 449%
$272 Calls – Range: .30-1.78 – Max Gain: 493%

Today, if the bonanza continues, we’ll look to roll up our strike prices to the 272.50-274 Calls today.


Under Armour, Inc. UAA – Final Update

This is the fourth day this week we’ve been tracking our UAA calls that we submitted in our premarket report on Tuesday, the UAA Weekly $15.50-16.50 Calls. We wanted to circle back around one last time to provide an update on the ranges we observed this week.

The lows listed represent those from Tuesday, and the highs were all registered yesterday, so the percentage figures given represent a three day overall upswing:

$15.50 Calls – Range: .60-2.85 – Max Gain: 375%
$16 Calls – Range: .34-2.38 – Max Gain: 600%
$16.50 Calls – Range: .16-2.00 – Max Gain: 1150%
_______

Fresh Options Ideas

Deere & Co. DE Weekly $167.50 Calls*
The Coca-Cola Co. KO Weekly $45* & 02/23 $46 Calls

*Please do not attempt to trade weekly options on a Friday unless you are an expert level trader with disposable funds.


Extended Watchlist:
NVAX, NSPR, MULE, SDRL, WEN, BPMX, AXL, HK(Form-4 Buy)

Blue Horseshoe Stocks: SPY Calls & More

SPDR S&P500 ETF (SPY)

After the previous two sessions of backsliding for the markets at large, today we could be in line to see a reversal, especially after a high impact jobs report which exceeded expectations, as the private sector added 234K jobs in January when 190K was the expected figure.

We’re going to focus on the SPY as we often do when we’re looking for a market analog, and signal some contracts for observation; the SPY Weekly $282-284 Calls.



The Boeing Co. BA

We also want to give our attention to Boeing this morning in the wake of a very positive earnings report. In addition to a beat on profits, the company boosted its 2018, including ratcheting up production of Jetliners by 7%.

As a result the stock soared in premarket trading, past previous resistance and into blue skies. We’ll look for a classic dip-and-rip scenario and turn our attention to the BA Weekly $352.50-360 Calls.


Extended Watchlist:
KCPC, NSPR, GEH, MTOR, MARA

Blue Horseshoe Stocks: CVS Options & More

CVS Health Corp CVS

First up this morning, we’re taking a look at CVS, which is currently boasting an interesting chart setup along with a recent analyst upgrade.

The stock recently ran to an area of previous resistance near $84, and is currently down in the premarket along with the markets in general, but we’re going to be looking for a recovery.

As you can see on the annotated chart below, there appears to be an impending Golden Cross, with the 50DMA rising toward the 200DMA, and with the company’s quarterly earnings call slated for February 8th, we’re going to signal some options that could see some nice activity.

We’re going to radar the CVS 02/09 $77-80 Calls which will expire at the end of next week, and could explode with a favorable quarterly report.


Ballard Power Systems, Inc. BLDP – Update

We couldn’t have timed yesterday morning’s call of BLDP any better, outlining the reasons we thought the stock was ripe for a reversal. Among other things, it had strung together ten consecutive sessions of decreases or sideways trading, and yesterday brought the beginning of the rebound that we suspected was due.

From an early low of 3.39, BLDP made a modest, yet convincing move of 19% to a high of 4.04, before closing very near to the high of day at 4.02. It’s a good start, and we’ll want to see the stock continue to record higher highs and higher lows, and show some signs of sustaining its momentum.

Adding to the possibility of a continued uptrend is a PR regarding the company’s Protonex subsidiary this morning outlining a government purchase order of $1.6M for its power management systems for special operations military equipment.(>>View PR)


Extended Watchlist:
ALV, EXTR, FCSC, MNTA, PTI, NSPR, TVIX